Cubist Systematic Strategies, LLC Abb Vie Inc. Put Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $983,040 - $1.2 Million	6,000 Added 60.0%	16,000 $3.16 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $123,832 - $144,608	800 Added 8.7%	10,000 $1.72 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $8.97 Million - $10.2 Million	-56,100 Reduced 85.91%	9,200 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $3.8 Million - $4.28 Million	-27,600 Reduced 29.71%	65,300 $10.1 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.94 Million - $2.24 Million	14,500 Added 18.49%	92,900 $13.8 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $5.26 Million - $6.55 Million	-39,700 Reduced 33.62%	78,400 $10.6 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $2.46 Million - $2.83 Million	-17,000 Reduced 12.58%	118,100 $18.8 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $9.6 Million - $11.5 Million	69,400 Added 105.63%	135,100 $21.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $4.58 Million - $5.25 Million	34,100 Added 107.91%	65,700 $8.82 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $4.35 Million - $5.53 Million	31,600 New	31,600 $4.84 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.